Middle East and Africa Bladder Disorders market is expected to reach USD 519.60 million by 2029

Published November 6, 2023

Market research report will help assess the market to identify both key players and those on the rise. The competitors are taking away customers and win in the marketplace because they’ve done their research earlier than others. Furthermore, understanding the weaknesses in competitor’s approach helps to fill the gaps that that give more customers. Knowledge about what performed the best for the competition will help to think to think more creatively while modelling a new strategy. Knowing as much as possible about the competition/competitor will be pivotal to the success of any business. And that’s where Middle East and Africa Bladder Disorders market report is vital.

Bladder disorders are a group of disorders that can affect human life’s daily activity. Some of the most common bladder disorders are cystitis- in which the bladder is infected and causes inflammation. Urinary incontinence- loss of bladder control, interstitial cystitis- bladder pain and frequent, urgent urination, and the overactive bladder– a condition in which the bladder squeezes urine. Bladder disorders can affect the quality of life and cause other health problems. Health changes and issues, including nervous system and lifestyle factors, can cause or contribute to UI in men and women.

Download the PDF Sample Report:  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=middle-east-and-africa-bladder-disorders-market&Shri

The most common bladder disorders are overactive bladder and UI. These problems are associated with the nervous system. Nerves carry messages from the brain to the bladder, indicating muscles contract or release.

Middle East and Africa bladder disorders market are expected to grow in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.0% in the forecast period of 2022 to 2029 and is expected to reach USD 519.60  million by 2029 from USD 327.73  million in 2021.



Bladder disorders are a number of bladder issues that can affect daily physical activities. The most common bladder disorders are cystitis, interstitial cystitis, overactive bladder, urinary incontinence, and bladder cancer. Most bladder issues are caused by a bacterial infection that enters the urinary tract.

Various strategic initiatives by the market players in terms of collaboration, acquisition, partnership, and others, allow them to increase their company’s product portfolio, leading to market expansion and hence enhancing the product demand among customers, which ultimately provides the market players to earn maximum revenue.


Aging is a strong risk factor that can associate with bladder-related disorders. Aging prompts neurologic, anatomic, and biochemical changes in bladder function, which can lead to the development of OAB. Overactive bladder is the most common problem among the geriatric population. Aging population is suffering from various bladder-associated problems and disorders due to which they are the predominant users of chronic health management services and solutions.

According to the noble study, the prevalence rate of overactive bladder is approximately 16.9 in women and men, around 16.0%, and the prevalence of OAB is growing with age. However, there are treatment guidelines that specify the preferred first-, second-, and third-line OAB therapy strategies. Bladder disorders are associated with Neurologic disorders such as dementia, and in this age group, OAB is very challenging for the senior population. Over the last few decades, the old age population has been drastically growing worldwide.


Nowadays, various treatment options and innovative therapies are available for OAB and other bladder disorders. Many biopharmaceutical and pharmaceutical companies are investing in various unconventional therapies for bladder disorders, which are expected to launch during the forecast period.


Combination Therapies are much more effective than monotherapy, without additional side effects. Combination Therapies are a safe and effective alternative for individuals with refractory bladder conditions. Combining different target therapy strategies is the best approach to relieve patients of bladder disorders. Oral medication and behavioral therapy should be considered for the patients’ refractory treatment. Various advanced target therapies are available such as sacral neuromodulation, intradetrusor injection of a botulinum toxin A and percutaneous tibial nerve stimulation. These are advanced treatments and more effective as compared to oral agents.

Recent Development

  • In March 2020, Astellas Pharma Inc. revealed that the U.S FDA approved Myrbetriq® (mirabegron extended-release tablets) for the treatment of NDO in pediatric patients aged three years and older who weigh 35 kg or more, and Myrbetriq® Granules (mirabegron for extended-release oral suspension) for the treatment of neurogenic detrusor over activity (NDO) in pediatric patients aged three years and older. This approval will increase the drug’s global presence and elevate the company’s revenue

View the Comprehensive Report:  https://www.databridgemarketresearch.com/reports/middle-east-and-africa-bladder-disorders-market?Shri


Some of the major players operating in the Middle East and Africa bladder disorders market are Medtronic, Laborie, Boston Scientific Corporation, Pfizer Inc., Astellas Pharma Inc., KYORIN Pharmaceutical Co., Ltd. (A subsidiary of KYORIN Holdings, Inc.), Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Axonics, Inc., Merck & Co., Inc., Viatris Inc., Gaylord Chemical Company, L.L.C., Coloplast Corp, AbbVie Inc., Sun Pharmaceutical Industries Ltd., Zydus Group, Swati Spentose, Urovant Sciences among others.

Middle East and Africa Bladder Disorders Market Scope

Middle East and Africa bladder disorders market are segmented into type, treatment type, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.


On the basis of type, the Middle East and Africa bladder disorders market is segmented into cystitis, urinary incontinence, overactive bladder, interstitial cystitis, bladder cancer

Treatment type

  • Surgery
  • Medications
  • Others

On the basis of product, the Middle East and Africa bladder disorders market is segmented into surgery, medication, and others

End User

  • Hospital
  • Clinics
  • Ambulatory Surgery centers
  • Others

On the basis of end users, the Middle East and Africa bladder disorders market is segmented into hospitals, clinics, ambulatory surgery centers, and others

Distribution Channel

  • Direct
  • Retail

Key Advantages of the Report: 

  • This study provides an analytical overview of the industry, including current trends and future predictions to identify potential investment opportunities.
  • The report offers insights into key drivers, limitations, and prospects, along with a comprehensive market share analysis.
  • The report quantitatively assesses the current market, shedding light on its growth prospects.
  • A Porter’s five forces analysis gauges the bargaining power of buyers and suppliers in the market.
  • The report delivers an in-depth market analysis that considers competitive dynamics and forecasts the future competitive landscape.

What to Anticipate from the Report – A 7-Point Guide:

  • The report delves into the holistic strategy and innovation within the market ecosystem.
  • It highlights prominent market drivers and obstacles, providing clarity on technological standardization and regulatory frameworks.
  • The report evaluates various implementation models and examines numerous use cases.
  • Serving as a valuable resource, the report offers essential industry insights, showcasing information on new investments, stakeholders, relevant contributors, and market participants.
  • Through the forecast period, the report conducts a thorough market analysis, referencing historical developments, ongoing events, and future growth prospects.

Top DBMR Healthcare Reports:         

Aesthetic/Cosmetic Lasers Market – Industry Trends and Forecast

Pharmaceutical Laboratory Information Management Systems Market – Industry Trends and Forecast

Automated Sample Storage Systems Market – Industry Trends and Forecast

Glaucoma Market – Industry Trends and Forecast

Clinical Trials Market – Industry Trends and Forecast

Esthetic Dental Restoration Products Market – Industry Trends and Forecast

Fractional Laser Market – Industry Trends and Forecast

Microbubble Contrast Media Market – Industry Trends and Forecast

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com

CDN Newswire